The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mary, J. Y., & Modigliani, R. (1989) · Gut · doi:10.1136/gut.30.7.983 · Cited by 884
Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90121-3 · Cited by 743
Rutgeerts, P., van Assche, G., Vermeire, S., D’Haens, G., Baert, F., Noman, M., Aerden, I., de Hertogh, G., Geboes, K., Hiele, M., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.01.010 · Cited by 418
Bull, T. J., McMinn, E. J., Sidi-Boumedine, K., Skull, A., Durkin, D., Neild, P., Rhodes, G., Pickup, R., & Hermon-Taylor, J. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.7.2915-2923.2003 · Cited by 403
Chiodini, R. J., Van Kruiningen, H. J., Thayer, W. R., Merkal, R. S., & Coutu, J. A. (1984) · Digestive Diseases and Sciences · doi:10.1007/bf01317078 · Cited by 332
Prantera, C., Zannoni, F., Scribano, M. L., Berto, E., Andreoli, A., Kohn, A., & Luzi, C. (1996) · PubMed · Cited by 309
Peters, D. H., & Clissold, S. P. (1992) · Drugs · doi:10.2165/00003495-199244010-00009 · Cited by 295
Colombel, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00816-8 · Cited by 254
Isolation of Mycobacterium avium subsp paratuberculosis from breast milk of Crohn's disease patients
Naser, S. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00746-2 · Cited by 232
Thayer, W. R., Coutu, J. A., Chiodini, R. J., Van Kruiningen, H. J., & Merkal, R. S. (1984) · Digestive Diseases and Sciences · doi:10.1007/bf01317079 · Cited by 226
Combined budesonide and antibiotic therapy for active Crohn's disease: A randomized controlled trial
Steinhart, A. H., Feagan, B. G., Wong, C. J., Vandervoort, M., Mikolainis, S., Croitoru, K., Seidman, E., Leddin, D. J., Bitton, A., Drouin, E., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34225 · Cited by 216
Preliminary Study of Ciprofloxacin in Active Crohn's Disease
Arnold, G. L., Beaves, M. R., Pryjdun, V. O., & Mook, W. J. (2002) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200201000-00002 · Cited by 181
Does Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease?: Table 1
Sartor, R. B. (2005) · Gut · doi:10.1136/gut.2004.055889 · Cited by 175
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics
Gui, G. P., Thomas, P. R., Tizard, M. L., Lake, J., Sanderson, J. D., & Hermon-Taylor, J. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.3.393 · Cited by 163
Brogden, R. N., & Fitton, A. (1994) · Drugs · doi:10.2165/00003495-199447060-00008 · Cited by 131
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease
Shafran, I., Kugler, L., Kl-Zaatari, F. A. X., Naser, S. A., & Sandoval, J. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80055-x · Cited by 114
Treatment of severe Crohn's disease using antimycobacterial triple therapy — approaching a cure?
Borody, T. J., Leis, S., Warren, E. F., & Surace, R. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80056-1 · Cited by 113
Prantera, C., Kohn, A., Mangiarotti, R., Andreoli, A., & Luzi, C. (1994) · PubMed · Cited by 112
Open label trial of oral clarithromycin in active Crohn’s disease
Leiper, Morris, & Rhodes (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00753.x · Cited by 92
Controlled trial of antimycobacterial therapy in Crohn's disease: Clofazimine versus placebo
Afdhal, N. H., Long, A., Lennon, J. R., Crowe, S. F., & O’Donoghue, D. P. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01298873 · Cited by 84
Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?
Greenstein, R. J., & Collins, M. T. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16781-0 · Cited by 76
The Mycobacteria Story in Crohn's Disease
Shanahan, F., & O’Mahony, J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50358.x · Cited by 71
Randomized controlled trial of clarithromycin and ethambutol in the treatment of Crohn’s disease
Goodgame, R., Kimball, K., Akram, S., Ike, E., Ou, C. N., Sutton, F. M., & Graham, D. Y. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01099.x · Cited by 54
Rastogi, N., Goh, K. S., & Labrousse, V. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.12.2843 · Cited by 53
Hultén, K. G., Almashhrawi, A. A., El-Zaatari, F. A., & Graham, D. Y. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005453409445 · Cited by 47
Effects of Macrolides and Ketolides on Mycobacterial Infections
Bermudez, L. E., & Yamazaki, Y. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383241 · Cited by 14
Cited by
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Baumgart, D. C., & Sandborn, W. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60026-9 · Cited by 2,154
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Gut microbiota and IBD: causation or correlation?
Ni, J., Wu, G. D., Albenberg, L., & Tomov, V. T. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.88 · Cited by 1,778
Epidemiology and risk factors for IBD
Ananthakrishnan, A. N. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.34 · Cited by 1,741
Metadata
- Authors
- Selby, W., Pavli, P., Crotty, B., Florin, T., Radford-Smith, G., Gibson, P., Mitchell, B., Connell, W., Read, R., Merrett, M., Ee, H., & Hetzel, D.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 132
- Issue
- 7
- Pages
- 2313-2319
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2128474861
- Cited by
- 362
- References
- 26
- FWCI
- 24.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.